Sofinnova Partners SAS, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 491,109 shares at $13.00 ($3.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $3.0M FLXN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 260,340 | $0 | 0.0% |
| 2 | $13.00 | 230,769 | $3.0M | 100.0% |
| Total | $6.11 avg | 491,109 | $3.0M | 100% |
| Filing → |
| HOOK | SELL | 2021-03-31 | $963K | — | Filing → |
| HOOK | SELL | 2021-03-29 | $749K | — | Filing → |
| HOOK | SELL | 2021-03-26 | $722K | — | Filing → |